Nxera Pharma Co., Ltd. (4565.T) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Nxera Pharma Co., Ltd., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -5.96x |
| P/B Ratio | 1.22x |
| P/S Ratio | 2.52x |
| Profitability | |
| Gross Margin | 72.3% |
| Operating Margin | -27.9% |
| Net Margin | -42.3% |
| EBITDA Margin | -13.2% |
| Liquidity | |
| Current Ratio | 2.54x |
| Quick Ratio | 1.90x |
| Leverage | |
| Debt/Equity | 0.94x |
YoY = year-over-year change. Source: FMP..